These data indicate the high incidence of activation of TGFβ1-ZEB2NAT-ZEB2 axis in human bladder cancer patients, rendering high migration and invasion capabilities to the bladder cancer cells. This evidence concerns the gene ZEB2 and urinary bladder carcinoma.